Q1 2025 · 13F-HR
STEMPOINT CAPITAL LPholdings as filed
Filed 2025-05-15 · accession 0001420506-25-001189
$313.7M
Reported value
61
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $26.0M | 8.29% | 2,578,860 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $19.6M | 6.26% | 1,598,594 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $18.2M | 5.80% | 566,212 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $18.0M | 5.73% | 273,774 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $14.6M | 4.65% | 346,756 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $14.6M | 4.65% | 853,472 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $13.6M | 4.32% | 40,936 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $13.5M | 4.30% | 190,401 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $11.3M | 3.59% | 318,782 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $9.2M | 2.94% | 342,062 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $9.2M | 2.94% | 274,633 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $9.1M | 2.89% | 667,078 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $8.5M | 2.72% | 593,335 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $7.7M | 2.47% | 731,039 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.2M | 2.30% | 208,437 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $7.1M | 2.26% | 289,823 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $7.0M | 2.24% | 159,305 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $6.9M | 2.19% | 440,073 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.6M | 2.12% | 87,059 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $6.4M | 2.02% | 192,352 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $6.3M | 2.02% | 156,185 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $6.0M | 1.92% | 250,564 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.0M | 1.92% | 149,648 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $5.5M | 1.75% | 61,927 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $5.1M | 1.63% | 2,366,554 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $5.1M | 1.62% | 1,190,579 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $4.5M | 1.42% | 386,837 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $4.0M | 1.26% | 180,255 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $2.8M | 0.90% | 240,826 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.4M | 0.76% | 49,241 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $2.4M | 0.76% | 120,430 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $2.3M | 0.74% | 21,052 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.3M | 0.73% | 14,732 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.3M | 0.72% | 200,900 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $2.2M | 0.70% | 136,139 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $2.2M | 0.70% | 268,919 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.1M | 0.68% | 104,585 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $1.8M | 0.57% | 33,816 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $1.6M | 0.52% | 467,882 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $1.5M | 0.49% | 150,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.5M | 0.49% | 960,307 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $1.1M | 0.35% | 66,999 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $954,855 | 0.30% | 26,421 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $912,754 | 0.29% | 124,523 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $883,138 | 0.28% | 84,430 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $797,025 | 0.25% | 11,155 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $739,519 | 0.24% | 725,019 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $733,155 | 0.23% | 198,150 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $725,851 | 0.23% | 89,833 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $713,019 | 0.23% | 96,615 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $627,600 | 0.20% | 60,000 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $613,426 | 0.20% | 47,078 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $237,500 | 0.08% | 50,000 | PUT | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $165,058 | 0.05% | 64,100 | PUT | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $93,750 | 0.03% | 125,000 | PUT | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $42,500 | 0.01% | 100,000 | CALL | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $32,500 | 0.01% | 100,000 | CALL | SOLE |
| 26923G301 | BBC | ETFIS SER TR I | $16,563 | 0.01% | 132,500 | CALL | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $15,500 | 0.00% | 10,000 | CALL | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $8,344 | 0.00% | 151,700 | CALL | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $3,793 | 0.00% | 151,700 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.